Anastrozole and MENT Interaction

Compatible
Researched 90% confidence

Anastrozole and MENT have a compatible interaction with 90% confidence. Aromatase inhibitors have reduced efficacy with MENT because its aromatization product, 7-alpha-methyl-estradiol, is a methylated estrogen that is less effectively blocked by conventional AIs. Anastrozole will still provide some estrogen control but typically not as complete as when managing estrogen from testosterone. Users may need higher AI doses than expected, and some find AIs insufficient at higher MENT doses. Monitor symptoms and bloodwork closely -- standard estradiol assays may not fully capture 7-alpha-methyl-estradiol levels. Both compounds affect the gonads and heart and liver, so monitoring these systems is recommended.

Compound Profiles

Anastrozole

Aromatase Inhibitor | Estrogen Management

Anastrozole competitively binds to the heme group of the aromatase enzyme (cytochrome P450 19A1), reversibly inhibiting its catalytic activity. Aromatase is responsible for the final step in estrogen biosynthesis, converting testosterone to estradiol and androstenedione to estrone in peripheral tissues including adipose, muscle, liver, and brain.

Half-life: ~40-50 hours Typical dose: 0.25-0.5mg EOD or E3D (estrogen management) pct, anabolic
aromatase androgenicaromatase inhibitorestrogenichepatotoxic
View full profile

MENT

19-Nor Anabolic Steroid | Experimental TRT Alternative

MENT binds to the androgen receptor with high affinity, estimated at roughly 10 times the potency of testosterone, driving robust activation of AR-dependent gene transcription pathways responsible for protein synthesis, nitrogen retention, and satellite cell proliferation in skeletal muscle. Its 7-alpha methyl group renders it resistant to 5-alpha reductase, meaning it is not converted to a reduced metabolite in androgen-sensitive tissues the way testosterone is converted to DHT or nandrolone is converted to DHN.

Half-life: ~40 minutes (acetate ester) Typical dose: 5-25 mg/day (acetate) anabolic, sexual health
5 alpha reductaseandrogen receptorepo receptorestrogen receptor androgenicaromatase inhibitorblood pressure raisingcarcinogenic risk
View full profile

Combined Organ Load

Gonads
elevated
Heart
moderate
Liver
moderate
Pituitary
low

Shared Safety Flags

2x 2 androgenic compounds (Anastrozole, MENT). Additive androgenic load — increased risk of hair loss, acne, prostate effects.
2x 2 compounds share the aromatase-inhibitor safety flag (Anastrozole, MENT). Monitor accordingly.
2x 2 estrogenic compounds (Anastrozole, MENT). Combined estrogen elevation — monitor E2 and consider aromatase inhibitor.
2x 2 HPTA-suppressive compounds (Anastrozole, MENT). Deep hormonal shutdown expected — plan extended PCT.
2x 2 compounds disrupt lipids (Anastrozole, MENT). Get lipid panel mid-cycle — consider adding lipid support.
2x 2 compounds share the teratogenic safety flag (Anastrozole, MENT). Monitor accordingly.

Frequently Asked Questions

Can I take Anastrozole with MENT?

Yes, Anastrozole and MENT can generally be taken together. Aromatase inhibitors have reduced efficacy with MENT because its aromatization product, 7-alpha-methyl-estradiol, is a methylated estrogen that is less effectively blocked by conventional AIs. Anastrozole will still provide some estrogen control but typically not as complete as when managing estrogen from testosterone. Users may need higher AI doses than expected, and some find AIs insufficient at higher MENT doses. Monitor symptoms and bloodwork closely -- standard estradiol assays may not fully capture 7-alpha-methyl-estradiol levels.

Is Anastrozole and MENT safe together?

Based on documented research, this combination is considered compatible. However, shared safety flags include: androgenic, aromatase inhibitor, estrogenic, hpta suppressive, lipid disrupting, teratogenic. Monitor accordingly.

What are the interactions between Anastrozole and MENT?

Aromatase inhibitors have reduced efficacy with MENT because its aromatization product, 7-alpha-methyl-estradiol, is a methylated estrogen that is less effectively blocked by conventional AIs. Anastrozole will still provide some estrogen control but typically not as complete as when managing estrogen from testosterone. Users may need higher AI doses than expected, and some find AIs insufficient at higher MENT doses. Monitor symptoms and bloodwork closely -- standard estradiol assays may not fully capture 7-alpha-methyl-estradiol levels. This assessment has 90% confidence and is based on documented research data.

How should I time Anastrozole and MENT?

Anastrozole has a half-life of ~40-50 hours and MENT has a half-life of ~40 minutes (acetate ester). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Anastrozole vs MENT

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.